A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
PHASE2
An 84-day, prospective, randomized (1:1) vehicle controlled, double-masked ...
MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
N/A
Aim of the work The aim of this study is to compare the role of musculoskel...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09
Trial ID
NCT05545098
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
PHASE2
rhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Austr...